Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration

The aim of this cross‐sectional study was to examine whether a history of selective estrogen receptor modifiers (SERMs), tamoxifen and raloxifene, use was associated with cognitive performance, odds of mild cognitive impairment (MCI), or magnetic resonance imaging (MRI) markers of neurodegeneration...

Descripción completa

Detalles Bibliográficos
Autores principales: Kara, Firat, Lohse, Christine M., Castillo, Anna M., Tosakulwong, Nirubol, Lesnick, Timothy G., Jack, Clifford R., Petersen, Ronald C., Olson, Janet E., Couch, Fergus J., Ruddy, Kathryn J., Kantarci, Kejal, Mielke, Michelle M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939086/
https://www.ncbi.nlm.nih.gov/pubmed/36040183
http://dx.doi.org/10.1002/cam4.5175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939086/
https://www.ncbi.nlm.nih.gov/pubmed/36040183
http://dx.doi.org/10.1002/cam4.5175

Ejemplares similares